UC professor’s method to treating cocaine addiction highlighted
WVXU, Local 12 report on researcher’s unique approach
The work of University of Cincinnati pharmacology professor Andrew Norman to treat cocaine addiction has been featured by WVXU and Local 12.
Norman and his team at UC and Cincinnati Children's Hospital Medical Center have developed a human-made protein that acts like a regular antibody in the immune system, called a monoclonal antibody, in an effort to treat cocaine addiction. The antibody binds to cocaine and prevents it from entering the brain.
The approach, which is awaiting Food and Drug Administration approval to proceed with first‐in‐human trials, offers hope of a potential treatment for people addicted to cocaine.
“They have to be motivated to want to quit and the cocaine and the antibody will help them quit by having no effect of cocaine," Norman told WVXU. "So they take the cocaine and the cocaine is neutralized and has no effect. And in that way, because it’s not having its effect it won’t induce a relapse response.”
Norman's approach is one that has been successful for other therapies, including COVID-19 vaccines.
“We came up with the idea of taking a so-called monoclonal antibody, and these are specific antibodies, and they are used therapeutically a lot these days for various things, including COVID-19,” Norman told Local 12.
Featured image at top: University of Cincinnati professor Andrew Norman, left, works in his lab. Photo/Colleen Kelley/UC Creative Services.
Impact Lives Here
The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.
Related Stories
Sugar overload killing hearts
November 10, 2025
Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.
Is going nuclear the solution to Ohio’s energy costs?
November 10, 2025
The Ohio Capital Journal recently reported that as energy prices continue to climb, economists are weighing the benefits of going nuclear to curb costs. The publication dove into a Scioto Analysis survey of 18 economists to weigh the pros and cons of nuclear energy. One economist featured was Iryna Topolyan, PhD, professor of economics at the Carl H. Lindner College of Business.
App turns smartwatch into detector of structural heart disease
November 10, 2025
An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.